Glow Blend (GHK-Cu/BPC-157/TB500)

The Glow Blend combines three peptides with complementary tissue-repair and skin-remodeling mechanisms. GHK-Cu (copper tripeptide-1) is the primary cosmetic-active component, directly stimulating collagen and glycosaminoglycan synthesis in dermal fibroblasts while modulating matrix metalloproteinases for organized tissue remodeling. Its gene expression effects span over 4,000 genes related to tissue repair, antioxidant defense, and inflammation suppression. BPC-157 adds a potent pro-angiogenic dimension to the blend. By upregulating VEGF and its receptors, BPC-157 promotes the formation of new blood vessels that are essential for delivering nutrients and oxygen to regenerating tissue. Its interaction with the nitric oxide system provides additional support for vascular function and tissue healing. BPC-157's broad cytoprotective properties complement GHK-Cu's remodeling activity. TB-500 (thymosin beta-4 fragment) contributes through its unique mechanism of sequestering G-actin monomers and promoting actin polymerization, which is the driving force behind cell migration. In wound healing, cell migration is often the rate-limiting step — keratinocytes and fibroblasts must physically move into the wound bed before repair can occur. TB-500 facilitates this migration while also exhibiting anti-inflammatory effects through suppression of NF-kB-mediated cytokine release. The combination of these three peptides addresses wound healing at multiple levels: vascular supply (BPC-157), matrix remodeling (GHK-Cu), and cellular migration (TB-500).

The Glow Blend combines three peptides with complementary tissue-repair and skin-remodeling mechanisms. GHK-Cu (copper tripeptide-1) is the primary cosmetic-active component, directly stimulating collagen and glycosaminoglycan synthesis in dermal fibroblasts while modulating matrix metalloproteinases for organized tissue remodeling. Its gene expression effects span over 4,000 genes related to tissue repair, antioxidant defense, and inflammation suppression. BPC-157 adds a potent pro-angiogenic dimension to the blend. By upregulating VEGF and its receptors, BPC-157 promotes the formation of new blood vessels that are essential for delivering nutrients and oxygen to regenerating tissue. Its interaction with the nitric oxide system provides additional support for vascular function and tissue healing. BPC-157's broad cytoprotective properties complement GHK-Cu's remodeling activity. TB-500 (thymosin beta-4 fragment) contributes through its unique mechanism of sequestering G-actin monomers and promoting actin polymerization, which is the driving force behind cell migration. In wound healing, cell migration is often the rate-limiting step — keratinocytes and fibroblasts must physically move into the wound bed before repair can occur. TB-500 facilitates this migration while also exhibiting anti-inflammatory effects through suppression of NF-kB-mediated cytokine release. The combination of these three peptides addresses wound healing at multiple levels: vascular supply (BPC-157), matrix remodeling (GHK-Cu), and cellular migration (TB-500).

As a blend, specific ratios vary by formulation. Individual component research doses: GHK-Cu at 1-10 micromolar topically; BPC-157 at 10 mcg/kg in animal models; TB-500 at 6 mg loading dose protocols in equine research.

Store lyophilized (freeze-dried) powder at -20°C to 4°C in a dry environment protected from light. Unreconstituted peptide is stable for extended periods when stored properly.

Once reconstituted with bacteriostatic water or an appropriate solvent, store at 2-8°C and use within the timeframe specified on the Certificate of Analysis. Avoid repeated freeze-thaw cycles.

A Certificate of Analysis documenting purity, identity, and recommended storage conditions is included with every order.